Phase II Randomized Trial Evaluting Aflibercept Associated With LV5FU2 Regimen as First Line Treatment of Non-resectalbe Metastatic Colorectal Cancers
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms FOLFA
- 11 Oct 2016 Trial design presented at the 41st European Society for Medical Oncology Congress.
- 26 May 2016 Status changed from active, no longer recruiting to recruiting.
- 18 Mar 2015 New trial record